By ipomarket.in Editorial Team · Last reviewed: 2026-09-26
Disclaimer: This article is for informational purposes only and does not constitute investment advice. IPO investments are subject to market risks. Please read the offer document carefully and consult a SEBI-registered investment advisor before investing.
When a newly listed stock is up 40% on debut, it is tempting to call the IPO a success. But a listing-day gain tells you almost nothing about whether the company created value for a shareholder over the following months. To judge that honestly, you have to compare the stock against a benchmark, over sensible time horizons, and with the noise of the listing day stripped out.
This guide explains how to do that comparison the way analysts do it: against the broad market, against the right sector index, and against a cohort of other recent listings. It is a framework, not a recommendation to buy or sell anything.
Why a raw return is not enough
Suppose an IPO you tracked is up 15% three months after listing. Good result? It depends. If the Nifty 50 rose 18% in the same period, the stock actually lagged the market. If the Nifty 50 was flat, the same 15% looks far more impressive. A return in isolation has no meaning until you place it next to what you could have earned elsewhere with similar risk.
This is the core idea behind benchmarking: measure relative performance, not absolute. Regulators already apply this thinking in managed products. SEBI introduced performance benchmarking and categorisation for the portfolio management services (PMS) industry, similar to mutual fund norms, so investors can compare providers on a like-for-like basis. The same principle transfers cleanly to how you should assess a listed IPO.
The three benchmarks that matter
There is no single "correct" benchmark. Each answers a different question.
1. Nifty 50 — the broad market question
Comparing an IPO to the Nifty 50 answers a simple question: did I do better or worse than just holding the market? This is the baseline every investor should check first. It works for any IPO regardless of sector.
2. The sector index — the fair peer question
A broad-market comparison can flatter or punish a stock unfairly. A pharma IPO should really be measured against pharma peers, not against a market where IT and banking dominate. NSE publishes a wide range of sectoral indices, each tracking listed companies in a single industry, including Nifty Bank, Nifty Financial Services, Nifty IT, Nifty Auto, Nifty FMCG, Nifty Pharma, Nifty Healthcare, Nifty Metal, Nifty Realty, Nifty Media, Nifty Consumer Durables and Nifty Oil & Gas. Each is calculated using the free-float market-capitalisation method.
Sector indices are more concentrated and more volatile than the Nifty 50, which is exactly why they matter. If your pharma IPO fell 8% but Nifty Pharma fell 15%, the stock actually outperformed its peers even though it lost money. Matching the sector gives you the fairest read.
3. The Nifty IPO index — the cohort question
The Nifty IPO index tracks the performance of companies that have recently listed through an IPO, capturing their returns for a defined period after debut. It effectively answers: how did this IPO do compared with the batch of other recent IPOs? If your listing beat the market but lagged the IPO index, it means new listings as a group were running hotter than the stock you held.
Using all three together gives a rounded picture rather than a single flattering number.
Strip out the listing-day pop
The single biggest mistake retail investors make is including the debut gain in their performance maths. The listing-day move is driven by allotment scarcity and short-term sentiment, not by the business.
Institutional methodology recognises this. Dimensional, in a widely cited study, evaluated IPO returns by building a market-cap-weighted portfolio of IPOs issued over the preceding 12 months, rebalanced monthly, and deliberately excluded first-day returns to reduce the distortion from the allocation process. The lesson for a retail investor is the same: to judge the business, measure from the first-day closing price, not the offer price, when you are analysing sustained performance.
That distinction matters because the day-1 excitement fades. US market data (a different market, so treat it as context only) found that the average first-day pop of around 18% shrank to roughly 3% by month 12, and that 64% of IPOs underperformed the S&P 500 in their first year. Whether Indian IPOs behave the same way is not established, and India's market structure and investor base differ, so do not assume the numbers carry over. It simply illustrates why a strong debut is not a guarantee of a strong year.
Choosing the right time horizons
One month
The first month is dominated by listing-day euphoria, anchor unwinding and short-term trading. It is the least useful window for a long-term view, though it does tell you how quickly the debut premium held or faded.
Three months
This is the first genuinely useful checkpoint. Initial hype has cooled, and often one quarter of results as a listed company is available. Comparing the stock against the Nifty 50 and its sector index over three months starts to separate business quality from launch noise.
Twelve months
The twelve-month mark is where a real track record forms. By then the stock has faced multiple earnings cycles, and importantly, promoter and anchor lock-in periods begin to expire, which can add selling pressure. Tracking a stock across the full year, and watching what happens around lock-in expiry, often reveals far more than the debut ever did.
A step-by-step comparison method
- Fix your starting price. For sustained-performance analysis, use the first-day closing price. If you want to know your own return as an allottee, use the offer price separately, and label it clearly.
- Pick the matching benchmarks. Note the Nifty 50 level, the relevant sector index level (say Nifty IT for a software listing), and the Nifty IPO index level on the same start date.
- Record the levels at each horizon. Capture prices at one, three and twelve months for both the stock and each benchmark.
- Convert everything to percentages. Compute the percentage change for the stock and each benchmark over each window.
- Read the gap, not the number. Subtract the benchmark return from the stock return. A positive gap is outperformance; a negative gap is underperformance, even if the stock rose.
Doing this consistently is more valuable than any single data point. If you are new to reading listing behaviour, our note on when to sell or hold on listing day covers the short-term dynamics that muddy the one-month window.
Do not confuse GMP with performance
Grey market premium (GMP) is a pre-listing sentiment gauge, not a performance measure, and it can mislead badly. A recent case underlined this: for the NSE IPO in September 2026, the GMP was reported around 10-11% when the issue opened on 17 September, then fell to roughly 3-4% by listing, and the eventual listing premium was reportedly just 0.8%. That is one example, not a rule, but it shows how quickly grey-market expectations can diverge from reality. For how GMP actually works and its limits, see our explainer on IPO GMP.
Mainboard versus SME: use different lenses
SEBI applies different eligibility criteria to mainboard and SME IPOs. Mainboard companies list on the main NSE or BSE platforms and tend to be larger and more established, while SME issues list on NSE Emerge or BSE SME. That difference matters for benchmarking: comparing a small SME listing directly against the Nifty 50 can be misleading because the size, liquidity and volatility profiles are very different. Where a suitable index match does not exist, be honest that the comparison is imperfect rather than forcing it.
Where to find the data
You can track the Nifty IPO index and NSE sectoral indices through broker platforms and market-data aggregators. Live index levels are widely available; what is harder to source cleanly is aggregate historical data on how Indian IPO cohorts performed against the Nifty 50 over rolling 12-month windows, which is a genuine data gap for retail investors. Where you cannot find verified aggregate numbers, stick to comparing the individual stock you care about rather than quoting an average you cannot confirm.
FAQ
Which benchmark should I use to judge an IPO?
Use more than one. Compare against the Nifty 50 for a broad-market read, against the matching sector index (such as Nifty Pharma or Nifty IT) for a fair peer comparison, and against the Nifty IPO index to see how it did versus other recent listings. Each answers a different question.
Should I include the listing-day gain in my performance calculation?
For analysing the business over time, no. Institutional practice excludes first-day returns because they are driven by allotment scarcity and sentiment. Measure sustained performance from the first-day closing price, and keep any offer-price return as a separate, clearly labelled figure.
Is a high GMP a reliable sign the IPO will perform well?
No. GMP reflects pre-listing sentiment and can change sharply before listing. Recent examples show the actual listing premium landing far below the earlier GMP. Treat it as a mood indicator, not a performance forecast.
What time horizon gives the most honest picture?
The twelve-month window is the most informative because the stock has faced multiple earnings cycles and lock-in expiries by then. The one-month window is the least reliable because it is dominated by listing-day noise.
Can I compare an SME IPO to the Nifty 50?
You can, but be cautious. SME listings differ sharply from Nifty 50 constituents in size, liquidity and volatility, so the comparison is imperfect. Note the limitation rather than treating the gap as a clean read.
Last reviewed: 2026-09-26 by the ipomarket.in Editorial Team.